About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Quant Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSequent Scientific Limited8.8313147712630.0758
Domestic EquitiesZydus Wellness Ltd8.447564173028.7688
Domestic EquitiesSMS Pharmaceuticals Limited8.441890807128.7495
Domestic EquitiesAurobindo Pharma Limited7.705921730026.2433
Domestic EquitiesAster DM Healthcare Limited7.241944667124.6629
Domestic EquitiesAlivus Life Sciences6.950524629823.6705
Domestic EquitiesPfizer Ltd6.42604795421.8843
Domestic EquitiesANTHEM BIOSCIENCES LIMITED5.869733355419.9899
Domestic EquitiesAdani Enterprises Limited5.63579499619.1930
Domestic EquitiesDivi's Laboratories Limited3.62892042412.3586
Domestic EquitiesMedplus Health Services Limited3.520615007111.9899
Domestic EquitiesConcord Biotech Limited2.8804834729.8096
Domestic EquitiesGland Pharma Limited1.5223280765.1845
Total 77.1026 262.5806
Cash & Cash Equivalents and Net AssetsTREPS 02-Feb-2026 DEPO 1015.06365131551.3005
Cash & Cash Equivalents and Net AssetsNCA-NET CURRENT ASSETS-15.4779 -52.7114
Total -0.4143 -1.4109
Treasury Bills91 Days Treasury Bill 26-Feb-20260.87773000002.9891
Treasury Bills91 Days Treasury Bill 23-Apr-20260.87033000002.9639
Treasury Bills91 Days Treasury Bill 30-Apr-20260.86943000002.9609
Treasury Bills91 Days Treasury Bill 27-Mar-20260.58272000001.9843
Treasury Bills91 Days Treasury Bill 06-Feb-20260.29341000000.9992
Treasury Bills91 Days Treasury Bill 05-Mar-20260.29231000000.9954
Treasury Bills91 Days Treasury Bill 17-Apr-20260.29031000000.9888
Total 4.0761 13.8816
Derivatives-FuturesICICI Bank Limited4.786111970016.2995
Derivatives-FuturesLupin Limited4.59567267515.6506
Derivatives-FuturesDabur India Limited4.068827250013.8566
Derivatives-FuturesDivi's Laboratories Limited2.93951650010.0106
Derivatives-FuturesAurobindo Pharma Limited2.3200654507.9011
Total 18.7099 63.7184
RightsAdani Enterprises Limited PP RE0.5256113991.7901
Total 0.5256 1.7901
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.